ProfileGDS5822 / ILMN_2739692
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 59% 6% 40% 12% 27% 8% 50% 33% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 127.759
GSM1276600PDAC Late Ablation Control 210.16
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 11640
GSM1276603PDAC Late Ablation 29.112
GSM1276604PDAC Late Ablation 314.627
GSM1303940PDAC Late Ablation_anti-CTLA4 18.58
GSM1303941PDAC Late Ablation_anti-CTLA4 225.650
GSM1303942PDAC Late Ablation_anti-CTLA4 315.933